跳至主要内容
临床试验/ACTRN12619000462189
ACTRN12619000462189终止未知

Pilot Study: Effects of transcranial Direct Current Stimulation (tDCS) on cognitive functioning in regular, long-term cannabis consumers

niversity of Tasmania0 个研究点目标入组 20 人开始时间: 2019年3月20日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • General inclusion criteria: 18-50 years old, male and female, English-speakers, normal or corrected-to-normal vision
  • Cannabis group inclusion criteria: Individuals who have regularly (1+ days per week) used cannabis for 1+ year. We are not specifically recruiting individuals with cannabis use disorder (CUD); however, participants may meet criteria for CUD. Cannabis users will be asked to refrain from cannabis use 24 hours + prior to the Research Session.
  • Control group: No history of cannabis use or minimal (<50 lifetime uses) history of cannabis use

排除标准

  • General exclusion criteria:
  • No current or recent illicit drug use (in the past 30 days)
  • Dependence on alcohol (a dependency score of 20 or more on the Alcohol Use Disorder Identification Test) or other illicit substances, except nicotine
  • Pregnancy or suspected pregnancy
  • Known psychological problems (e.g., depression, anxiety, schizophrenia, PTSD); participants who self-report a clinical diagnosis will be excluded from the study,
  • Physical conditions or problems (such as cardiac problems and using related medication such as beta-blockers)
  • Metabolic diseases that would confound measures of metabolites (e.g., renal and kidney disease, phenylketonuria/PKU, tyrosinemia)
  • Use of prescribed medications to treat psychological conditions (e.g., anxiolytics, antidepressants) due to the potential interactive effect between tDCS and particular medications that could affect measures of cortical excitability
  • Brain stimulation contraindications:
  • Epilepsy or family history of epilepsy
  • History of neuropsychiatric conditions (e.g., stroke)
  • Skin compromised by pre-existing or current burns (e.g., sun burn), injuries, or conditions affecting the scalp (eczema or psoriasis on the head)
  • Pre-existing implants such as pacemakers and metal implants (excluding dental work such as tooth fillings, dental implants and non-ferromagnetic material). Any implant that is conductive, ferromagnetic or contains other magnetic-sensitive metals such as cochlea implants, stents, or implanted stimulators are contraindicated for TMS
  • Implanted electronic devices or intracranial magnetic clips such as aneurysm clips
  • Serious head injury or neurosurgery

研究者

发起方
niversity of Tasmania

相似试验